Selected article for: "case fatality rate and critical disease"

Author: Saeed, Sahrai; Rajani, Ronak
Title: The cardiovascular complications in COVID-19: Focus on acute cardiac injury
  • Cord-id: pevs9ugq
  • Document date: 2021_1_1
  • ID: pevs9ugq
    Snippet: At the end of 2019 a novel coronavirus was identified in Wuhan, China. The disease caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) was designated COVID-19 (corona virus disease 2019) by the World Health Organization in early 2020. Up to 80% of patients with COVID-19 experience mild symptoms with severe or critical disease occurring in the remaining 20%. Severe disease is manifested by the development of pneumonia, hypoxia and radiographic lung involvement whil
    Document: At the end of 2019 a novel coronavirus was identified in Wuhan, China. The disease caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) was designated COVID-19 (corona virus disease 2019) by the World Health Organization in early 2020. Up to 80% of patients with COVID-19 experience mild symptoms with severe or critical disease occurring in the remaining 20%. Severe disease is manifested by the development of pneumonia, hypoxia and radiographic lung involvement while critical disease indicates multiorgan involvement with significant respiratory or cardiac compromise. The current estimated case fatality rate from COVID-19 is approximately 1%. Epidemiological studies have shown that advanced age, male gender, previous chronic lung disease, cardiovascular and kidney disease, obesity and diabetes are risk factors for the severity of disease course. In the current focused review, we present an overview of the acute cardiovascular complications of COVID-19, their detection and impact upon prognosis.

    Search related documents:
    Co phrase search for related documents
    • active disease and acute impact: 1
    • active disease and long short: 1, 2, 3
    • active disease and long short term: 1, 2
    • active disease and longitudinal strain: 1
    • acute cardiac injury and liver enzyme: 1
    • acute cardiac injury and long short: 1, 2
    • acute cardiac injury and long short term: 1, 2
    • acute cardiac injury and longitudinal strain: 1, 2, 3, 4
    • acute coronary syndrome and long short: 1, 2, 3, 4, 5
    • acute coronary syndrome and long short term: 1, 2, 3, 4, 5
    • acute impact and long short: 1, 2, 3
    • acute impact and long short term: 1, 2, 3